Safety and Efficacy of Allogeneic Umbilical Cord Blood Therapy Combined With Erythropoietin in Children With Cerebral Palsy: a Double-blind, Randomized, Placebo-controlled Clinical Trial

Trial Profile

Safety and Efficacy of Allogeneic Umbilical Cord Blood Therapy Combined With Erythropoietin in Children With Cerebral Palsy: a Double-blind, Randomized, Placebo-controlled Clinical Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Epoetin alfa (Primary) ; Cord blood stem cell therapy
  • Indications Cerebral palsy
  • Focus Registrational; Therapeutic Use
  • Acronyms UCBnEPOinCP
  • Most Recent Events

    • 10 Oct 2017 Status changed from recruiting to completed.
    • 12 Jan 2014 New source identified and integrated (Clinical Research Information Service (CriS)- Republic of Korea; KCT0000950)
    • 29 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top